U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840899) titled 'CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury' on Feb. 17.
Brief Summary: The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI).
Participants will take Epidiolex (purified CBD) for 90 days
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Supra-sacral Spinal Cord Injury
Spinal Cord Injury
Urinary Incontinence
Intervention:
DRUG: CBD
Twice daily 100mg cannabidiol (CBD)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Wisconsin, Madison
Disclaimer: Curated by HT...